Literature DB >> 30248632

Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes.

Katherine L Wisner1, Dorothy Sit2, Kelly O'Shea3, Debra L Bogen4, Crystal T Clark2, Emily Pinheiro5, Amy Yang6, Jody D Ciolino6.   

Abstract

OBJECTIVE: The hypotheses were: (1) pregnant women with bipolar disorder (BD) have less favorable pregnancy outcomes than unaffected women, and (2) psychotropic treated women with BD have better outcomes than un-medicated women.
METHOD: This prospective study included 174 mother-infant dyads. Women had BD without psychotropic exposure (BD-NP, n = 38), BD with psychotropic treatment (BD-P, n = 49), or neither psychotropic exposure nor major mood disorder (Comp, n = 87). Maternal characteristics were completed at 20 weeks gestation and evaluated for associations with delivery and birth outcomes. We performed multiple regressions on infant outcomes with adjustment for maternal age, race, employment status, use of illicit drugs and pre-pregnancy BMI.
RESULTS: The BP-P, BP-NP and Comp groups varied significantly on sociodemographic characteristics. Women with BD were more likely to be less educated, unemployed, single, and use tobacco and illicit drugs than women in the Comp group. Compared to women with BD-NP, women with BD-P were more likely to be older and educated. Approximately 10% of all infants were delivered preterm. No significant differences in outcome occurred for APGAR scores < 8, NICU admissions, sex or infant length. Infants of mothers with BD-NP had significantly smaller head circumferences (HC) than the other groups, adjustment for confounding variables mitigated this association.
CONCLUSIONS: The overall pregnancy outcomes for women with BD were similar to those in the Comp group. The reduced HC in women with untreated BD appears due to factors related to disadvantaged sociodemographic status, a higher proportion of female births, and/or a protective effect of medication in the BD-P group.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Newborn; Perinatal psychiatry; Postpartum; Pregnancy; Psychopharmacology

Mesh:

Substances:

Year:  2018        PMID: 30248632      PMCID: PMC6548542          DOI: 10.1016/j.jad.2018.09.045

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  26 in total

Review 1.  Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Authors:  Eydie L Moses-Kolko; Debra Bogen; James Perel; Amy Bregar; Kathleen Uhl; Bob Levin; Katherine L Wisner
Journal:  JAMA       Date:  2005-05-18       Impact factor: 56.272

2.  Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders.

Authors:  Assen V Jablensky; Vera Morgan; Stephen R Zubrick; Carol Bower; Li-Anne Yellachich
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

Review 3.  The relationship between postpartum psychosis and bipolar disorder: a review.

Authors:  Linda H Chaudron; Ronald W Pies
Journal:  J Clin Psychiatry       Date:  2003-11       Impact factor: 4.384

4.  Bipolar illness, lithium prophylaxis, and pregnancy.

Authors:  E M van Gent; W M Verhoeven
Journal:  Pharmacopsychiatry       Date:  1992-07       Impact factor: 5.788

5.  Prevention of postpartum episodes in women with bipolar disorder.

Authors:  Katherine L Wisner; Barbara H Hanusa; Kathleen S Peindl; James M Perel
Journal:  Biol Psychiatry       Date:  2004-10-15       Impact factor: 13.382

6.  A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.

Authors:  Jaclyn L F Bosco; Rebecca A Silliman; Soe Soe Thwin; Ann M Geiger; Diana S M Buist; Marianne N Prout; Marianne Ulcickas Yood; Reina Haque; Feifei Wei; Timothy L Lash
Journal:  J Clin Epidemiol       Date:  2009-05-19       Impact factor: 6.437

Review 7.  Management of bipolar disorder during pregnancy and the postpartum period.

Authors:  Kimberly A Yonkers; Katherine L Wisner; Zachary Stowe; Ellen Leibenluft; Lee Cohen; Laura Miller; Rachel Manber; Adele Viguera; Trisha Suppes; Lori Altshuler
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

Review 8.  A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.

Authors:  Robert M Post; Gabriele S Leverich; Willem A Nolen; Ralph W Kupka; Lori L Altshuler; Mark A Frye; Trisha Suppes; Susan McElroy; Paul Keck; Heinze Grunze; Jorg Walden
Journal:  Bipolar Disord       Date:  2003-12       Impact factor: 6.744

9.  Searching for the puerperal trigger: molecular genetic studies of bipolar affective puerperal psychosis.

Authors:  Ian Jones; Nick Craddock
Journal:  Psychopharmacol Bull       Date:  2007

10.  Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.

Authors:  Adele C Viguera; Theodore Whitfield; Ross J Baldessarini; D Jeffrey Newport; Zachary Stowe; Alison Reminick; Amanda Zurick; Lee S Cohen
Journal:  Am J Psychiatry       Date:  2007-12       Impact factor: 18.112

View more
  2 in total

Review 1.  Lithium Use and Non-use for Pregnant and Postpartum Women with Bipolar Disorder.

Authors:  Alison Hermann; Alyson Gorun; Abigail Benudis
Journal:  Curr Psychiatry Rep       Date:  2019-11-07       Impact factor: 5.285

Review 2.  Course of Illness and Treatment Updates for Bipolar Disorder in the Perinatal Period.

Authors:  Melissa M Batt; Aviva K Olsavsky; Shaleah Dardar; Celeste St John-Larkin; Rachel L Johnson; Mary D Sammel
Journal:  Curr Psychiatry Rep       Date:  2022-02-15       Impact factor: 8.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.